Group B Strep Infection: Clinical Trials

6 trials for Group B Strep Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Completed 1

Follow Group B Strep Infection: new trials by email Literature Review of Group B Strep Infection trials Research Report on Group B Strep Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
mulTiplex Immunoassay qualiTy assuRance Panel
Collection of 50mls of blood - Group B Strep Infection
RecruitingSt George's, University of London502026-03-272026-05-01
Group B Streptococcus Response After Probiotic Exposure
Probiotic dietary supplement - Group B Strep Infection
Phase 3CompletedUniversity of New Mexico682020-12-242025-01-14
Serocorrelate of Protection Against GBS (PREPARE WP3)
Group B Streptococcus Carrier in Childbirth, Group B Streptococcal Infection, Late-Onset
UnknownSt George's, University of London6002020-04-012023-10-26
Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital
Group B Streptococcus Carrier in Childbirth, Group B Streptococcal Infection, Late-Onset
UnknownSt George's, University of London34232019-10-012023-11-24
Serosurveillance Study of Maternally Derived Anti-GBS Antibody
Group B Streptococcus Carrier in Childbirth, Group B Streptococcal Infection, Late-Onset
Active not recruitingSt George's, University of London60002019-04-242025-01-13
Group B Streptococcus Vaccine in Healthy Females
GBS-NN/NN2 with Alhydrogel® 25, Placebo GBS-NN/NN2 with Alhydrogel® 25, Placebo GBS-NN/NN2 with Alhydrogel® 50 - Group B Strep Infection
Phase 1CompletedMinervax ApS602019-01-092021-02-02

Narrower conditions

Streptococcal Infections (6)

Broader conditions

Bacterial Infections (6)  ·  Bacterial Infections and Mycoses (6)  ·  Gram-Positive Bacterial Infections (6)  ·  Infections (6)

Sponsors

St George's, University of London (4)  ·  Minervax ApS (1)  ·  University of New Mexico (1)

Countries

Uganda (4)  ·  United Kingdom (2)  ·  France (1)  ·  Italy (1)  ·  Malawi (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Geoff Kitson (1)  ·  Katrina Nardini (1)  ·  Kirsty Le Doare (1)  ·  Kirsty Le Doare, Dr (1)  ·  Kirsty Le Doare, Dr. (1)  ·  Kirsty Le Doare, Prof (1)  ·  Stephen Cose, Dr (1)

Results publications

PMID 40442923

NIH funding

2017 (1)